Abstract
Persistent human Papillomavirus (HPV) infections are now recognised as the leading cause of cervical cancer (CC). Approximately 100 types of human infecting HPV exist in nature and according to the samples collected from either pre-cancerous or cancerous lesions, almost ten are responsible for a good part of the CC cases. Two anti-HPV vaccines are currently registered worldwide - a tetravalent and a bivalent one - for which evidences of protecting effectiveness and safety have been delivered by controlled clinical trials and clinical practice. Consequently, and as a first step, several countries implemented HPV mass vaccination programmes for girls before the age of sexual debut. Moreover, and specifically for the bivalent vaccine, efficacy over various oncogenic types has been demonstrated in a broad population also including sexually active women that had potentially already acquired an HPV infection. The opportunity to extend the primary prevention to other cohorts of women up to the adult age through the use of the vaccine, improves the possibility to actively reduce the total number of CC cases. Based on two country examples, Italy and Belgium, different strategies for HPV vaccination of pre-adolescents, adolescents and young adults are discussed.
Keywords: Papillomavirus, anti-HPV vaccines, primary prevention, pre-adolescents, adolescents, young adults, immunogenic effects
Current Cancer Therapy Reviews
Title: HPV Vaccination in Adolescents: From Clinical Data to Implementation and Practice
Volume: 6 Issue: 2
Author(s): Franco Borruto and Karel Hoppenbrouwers
Affiliation:
Keywords: Papillomavirus, anti-HPV vaccines, primary prevention, pre-adolescents, adolescents, young adults, immunogenic effects
Abstract: Persistent human Papillomavirus (HPV) infections are now recognised as the leading cause of cervical cancer (CC). Approximately 100 types of human infecting HPV exist in nature and according to the samples collected from either pre-cancerous or cancerous lesions, almost ten are responsible for a good part of the CC cases. Two anti-HPV vaccines are currently registered worldwide - a tetravalent and a bivalent one - for which evidences of protecting effectiveness and safety have been delivered by controlled clinical trials and clinical practice. Consequently, and as a first step, several countries implemented HPV mass vaccination programmes for girls before the age of sexual debut. Moreover, and specifically for the bivalent vaccine, efficacy over various oncogenic types has been demonstrated in a broad population also including sexually active women that had potentially already acquired an HPV infection. The opportunity to extend the primary prevention to other cohorts of women up to the adult age through the use of the vaccine, improves the possibility to actively reduce the total number of CC cases. Based on two country examples, Italy and Belgium, different strategies for HPV vaccination of pre-adolescents, adolescents and young adults are discussed.
Export Options
About this article
Cite this article as:
Borruto Franco and Hoppenbrouwers Karel, HPV Vaccination in Adolescents: From Clinical Data to Implementation and Practice, Current Cancer Therapy Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339410791202592
DOI https://dx.doi.org/10.2174/157339410791202592 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification and Usage of Fluorescent Probes as Nanoparticle Contrast Agents in Detecting Cancer
Current Pharmaceutical Design Nanocrystals as Effective Delivery Systems of Poorly Water-soluble Natural Molecules
Current Medicinal Chemistry N-Succinyl Chitosan as Buccal Penetration Enhancer for Delivery of Herbal Agents in Treatment of Oral Mucositis
Current Drug Delivery Anionic Antimicrobial Peptides from Eukaryotic Organisms
Current Protein & Peptide Science Cell Death in Mammalian Development
Current Pharmaceutical Design Cytotoxic Effect of 5-Fluorouracil-loaded Polymer-coated Magnetite Nanographene Oxide Combined with Radiofrequency
Anti-Cancer Agents in Medicinal Chemistry A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
Current Drug Metabolism Fluorescent Cisplatin Analogues and Cytotoxic Activity
Current Medicinal Chemistry A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Current Drug Targets The Role of Epigenetics in Drug Resistance in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
Medicinal Chemistry Novel Insights Into c-Src
Current Pharmaceutical Design Calixarenes in Bio-Medical Researches
Current Medicinal Chemistry An Overview on the Development of New Potentially Active Camptothecin Analogs Against Cancer
Mini-Reviews in Medicinal Chemistry Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Biological Evaluation of the Salicylamide and Salicylic Acid Derivatives as Anti-Estrogen Agents
Medicinal Chemistry Natural Thiazoline-Based Cyclodepsipeptides from Marine Cyanobacteria: Chemistry, Bioefficiency and Clinical Aspects
Current Medicinal Chemistry Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews Control of Neuropathic Pain by Immune Cells and Opioids
CNS & Neurological Disorders - Drug Targets Protein Kinase C ζ Drives Sphingomyelin Metabolism in the Nucleus During Cell Proliferation
Current Chemical Biology